Potential endogenous epoxides of steroid hormones: Initiators of breast and other malignancies?

Medical Hypotheses

Volumn 69, Issue 6, 2007, Pages 1225-1229

  Soloway, Albert H ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; CARCINOGEN; CYTOCHROME P450; EPOXIDE; ESTROGEN; POLYCYCLIC AROMATIC HYDROCARBON; STEROID HORMONE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CARCINOGENICITY; EPOXIDATION; ESTROGEN METABOLISM; HUMAN; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; STEROID METABOLISM; TOXICOKINETICS;

BREAST NEOPLASMS; CARCINOGENS; DNA; EPOXY COMPOUNDS; ESTRADIOL; ESTROGENS; HORMONE REPLACEMENT THERAPY; HORMONES; HUMANS; METHYLCHOLANTHRENE; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MODELS, THEORETICAL; STEROIDS;

EID: 35449004116     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.04.023     Document Type: Article

References (24)

1. Weinberg RA. The biology of cancer; 2007. p. 479.
2. Shapiro CL. Categorizing cancer - breast cancer molecular subtypes. Frontiers-turning cancer discoveries into treatments. Fall 2006. p. 4-5.
3. Houtman JJ. Breast cancer, tamoxifen & beyond: estrogen and estrogen receptors. Breakthroughs in bioscience; 2006. p. 5.
4. DeVita Jr VT, Hellman S, Rosenberg SA. Cancer principles & practice of oncology; 1997. p. 1543.
5. Gapstur S.M., Morrow M., and Sellers T.A. JAMA 281 (1999) 2091
6. Miller E.C. Cancer Res 38 (1978) 1479-1496
7. Harvey RG. Polycyclic aromatic hydrocarbons: chemistry and carcinogenicity; 1991. p. 86.
8. Harvey R.G. Acc Chem Res 14 (1981) 218-226
9. Yager J.D., and Davidson N.E. New Engl J Med 354 (2006) 270-282
10. Stack D.E., Byun J., Gross M.L., Rogan E.G., and Cavalieri E.L. Chem Res Toxicol 9 (1996) 851-859
11. Mobley J.A., and Brueggemeier R.W. Carcinogenesis 25 (2004) 3-9
12. Russo J., Lareef M.H., Balogh G., Guo S., and Russo I.H. J Steroid Biochem Mol Biol 87 (2003) 1-25
13. Russo J., and Russo I.M. Trends Endocrinol Met 15 (2004) 211-214
14. Cavalieri E.L., and Rogan E.G. Ann NY Acad Sci 959 (2002) 341-354
15. Mobley J.A., and Brueggemeier R.W. Toxicol Appl Pharmacol 180 (2002) 219-226
16. Cavalieri E.L., Chakravarti D., Guttenplan J., Hart E., Ingle J., Jankowiak R., et al. Biochim Biophys Acta 1766 (2006) 63-78
17. Mobley J.A., Bhat A.S., and Brueggemeier R.W. Chem Res Toxicol 12 (1999) 270-277
18. LeQuesne P.W., Durga A.V., Subramanyam V., Soloway A.H., Hart R.W., and Purdy R.H. J Med Chem 23 (1980) 239-240
19. Weinberg RA. The biology of cancer; 2007. p. 485.
20. Rogan E.G., Badawi A.F., Devanesan P.D., Meza J.L., Edney J.A., West W.W., et al. Carcinogenesis 24 (2003) 697-702
21. Murray T.J., Maffini M.V., Ucci A.A., Sonnenschein C., and Soto A.M. Reprod Toxicol (2006) 10.1016/j. reprotox.2006.10.002
22. Soloway A.H., and LeQuesne P.W. J Theor Biol 85 (1980) 153-165
23. LeQuesne P.W., Abdel-Baky S., Durga A.V., and Purdy R.H. Biochem 25 (1986) 2065-2072
24. Menberu D., Nguyen P.V., Onan K.D., and LeQuesne P.W. J Org Chem 57 (1992) 2065-2072